Subject: Growth Hormone (GH) Therapy*. Effective Date: July 29, 2003. Department(s): Utilization Management. Policy: Treatment with GH (HCPCS J2941) is reimbursable under Plans. administered by QualCare, Inc. for the indications listed below. Objective: To provide proper and consistent reimbursement for and to ensure.
Branch and is intended to preserve the role of CRS as a confidential resource. decision whether and how to place individual CRS products in the public domain. congressional publications, or through their own web sites. CRS for individual congressional clients, should be maintained. interpreted broadly.
At 10:45 AM, the Defense Subcommittee will hold a closed hearing with US Central Command. This hearing will not be webcast. On Wednesday, March 29, the Labor, Health and Human Services Subcommittee will hold a budget hearing with Department of Health and Human Services Secretary Tom Price. Watch live at 10:00 AM.